Core Insights - The article discusses the emergence of "Synthetic Biological Intelligence" (SBI), which integrates living neurons with electronic devices, challenging the traditional silicon-based AI paradigm [1][13]. Group 1: Experiment Overview - The experiment conducted by Cortical Labs demonstrated that living neurons could learn to play the video game "Pong" without a physical body, showcasing their ability to perceive and react in a virtual environment [2][4]. - The system, named "DishBrain," consists of neurons from mouse embryos or human stem cells placed on a microchip, forming a mini brain that can interact with a simplified game [2][4]. Group 2: Mechanism of Interaction - The interaction between neurons and the game is facilitated by a high-density microelectrode array that sends electrical signals to the neurons based on the ball's position on the screen [4][5]. - Neurons control the paddle's movement by adjusting their firing rates in response to the game's feedback, creating a closed-loop system of learning [5][7]. Group 3: Learning Process - The neurons improved their gameplay by extending the duration of each game round, indicating enhanced accuracy in hitting the ball, achieved through a feedback mechanism based on the Free Energy Principle [7][8]. - The experiment confirmed that only neurons in a closed-loop feedback system exhibited learning capabilities, ruling out random fluctuations as a source of learning [8]. Group 4: Comparison of Neurons - Human-derived neurons outperformed mouse-derived neurons in the later stages of the game, suggesting differences in synaptic plasticity and information processing efficiency between species [9][11]. - The term "sentience" used in the study refers to the neurons' ability to respond adaptively to sensory inputs, not implying consciousness or emotional awareness [12]. Group 5: Implications for Synthetic Biological Intelligence - The findings of DishBrain suggest a new direction for technology, where living neurons could serve as computational units, potentially leading to more efficient and adaptive systems compared to traditional AI [13]. - Applications for DishBrain include drug testing and studying neurodegenerative diseases, highlighting its potential in real-world scenarios [13]. Group 6: Ethical Considerations - The advancement of systems like DishBrain raises ethical questions regarding the treatment of increasingly complex neural networks, prompting discussions on their moral status [14]. - The article emphasizes the need for ethical frameworks to address the implications of creating entities with adaptive capabilities [14]. Group 7: Conclusion - The DishBrain experiment illustrates that intelligence can emerge from simple rules of minimizing unpredictability, prompting a reevaluation of the nature of intelligence and its origins [15][16].

Group 1 - The core viewpoint of the article highlights the successful "upgrading" of 33 companies from the 2024 Cheetah Enterprises list, with 9 going public, 2 becoming unicorns, 19 entering the gazelle category, and 3 being acquired, showcasing the effectiveness of the capital market's "growth ladder" in supporting the transition from startup to maturity [1] - The A-share market has shown positive trends, driven by strong support from the technology growth sector, leading to an influx of hard technology companies attracting significant capital attention [1][2] - The three exit strategies—successful IPOs, upgrades to unicorn or gazelle status, and acquisitions—reflect different developmental needs and strategic choices of companies, indicating a multi-tiered capital market that meets the critical demands of tech innovation enterprises at various stages [1] Group 2 - The capital market has been guiding private equity funds to invest early, in smaller amounts, for the long term, and in hard technology, providing essential initial funding for early-stage tech companies and solidifying the foundation for unicorn cultivation [2] - The "upgrading" of Cheetah Enterprises reflects a closed loop of capital circulation in tech innovation, where smooth exit channels like IPOs and acquisitions provide key pathways for private equity funds and investors to realize value and returns [2] - Recent measures to optimize the exit environment for private equity funds, such as pilot programs for fund share transfers and adjustments to lock-up periods, aim to enhance long-term investment orientation and improve exit efficiency, thereby establishing a solid institutional foundation for a virtuous cycle of tech investment [2] Group 3 - The concentration of upgraded Cheetah Enterprises in sectors like biotechnology and artificial intelligence indicates that market funds are accurately flowing into key core technology areas prioritized by the state [3] - The collective "upgrading" of Cheetah Enterprises demonstrates the strong support of the capital market for technological innovation and highlights the increasingly clear and effective pathways for capital markets to serve the development of new productive forces [3] - The article asserts that the logic of investing in early-stage tech innovation in the Chinese capital market is valid, with clear profit logic and smooth exit pathways encouraging more social capital to become active participants in tech innovation investments [3]

数字背后，是传统提取模式日益逼仄的困境：国内血浆站监管趋严，导致资采浆成本飙升；而基于人源血浆的提取模式，理论上永远无法彻底规避未知病 毒跨物种传播的风险。 如今，传统意义上的地下血站基本根除，但非法的血液买卖链条并未消失，而是以一种更隐蔽、更具欺骗性的方式在运作。市场急需一种合规、安全、可 控、可大规模生产的替代来源。 这一次，破局的答案不再来自人，而是来自一只昆虫——蚕。 作为全球最大的人血白蛋白消费国，中国每年需消耗约1000吨，其中超60%长期依赖进口。 鉴于桑蚕丝腺是天然的高效"生物反应器"，位于安吉的链码生物科技有限公司，通过构建标准化的工业方舱养殖体系与家蚕表达系统，实现了重组蛋白的 低成本、可规模化生产。 链码生物创始人吴宇青形容，他们正在"低头开辟新时代"。一场用工业确定性替代生物不确定性的革命，正在链码生物的方舱里发生。 曾被寄予厚望的转基因动物乳腺反应器，虽然单体产量潜力巨大，但牛羊漫长的繁育周期和严苛的动物福利监管，给产业化套上了沉重的时间枷锁，难以 实现快速响应的工业化交付。 植物表达如水稻，则困于不确定性。田间种植成本低廉，但这种开放式系统面临着极高的基因漂移风险，监管压力巨大；且 ...

Core Viewpoint - Yushu Technology's robots are set to appear in the 2026 CCTV Spring Festival Gala, marking the company's third participation in this prestigious event, which significantly boosts its market visibility and commercial orders [1][2]. Group 1: Company Developments - Yushu Technology's robots have previously showcased their capabilities in high-difficulty performances, enhancing public perception of robotic technology [1]. - The competition for the 2026 Spring Festival Gala is intense, with rumors of multiple robotics companies bidding for a spot, indicating Yushu's technological stability and advanced product capabilities [1]. - The company is backed by Xinhua Wenhui, which has strategically invested in Yushu Technology, holding a stake through its investment platform [2]. Group 2: Investment and Strategic Partnerships - Xinhua Wenhui began its investment in Yushu Technology in 2024, contributing 100 million RMB, with Yushu's valuation reaching 12 billion RMB and an anticipated IPO in 2026 [2]. - The partnership between Xinhua Wenhui and leading humanoid robot company UBTECH is aimed at transforming hard technology capabilities into educational service value, exemplified by the "Panda Robot 'Youyou'" project [2]. - Xinhua Wenhui's investment strategy extends beyond robotics, including stakes in various high-tech sectors such as spatial computing and molecular diagnostics, showcasing a diversified investment approach [2][3]. Group 3: Industry Insights - Analysts note that as AI and embodied intelligence enter a commercial phase in 2026, Xinhua Wenhui is evolving from a traditional book distributor to a multifaceted platform with cultural, educational, and hard technology investment capabilities [3]. - The synchronized performance of Yushu Technology's robot clusters at the Spring Festival Gala reflects a broader trend of integrating culture and technology within the industry [3].

Group 1 - The core point of the article highlights the significant impact of the China-South Korea Free Trade Agreement (FTA) on trade facilitation, with the Yanji Customs issuing nearly 2,000 certificates of origin over the past five years, valued at approximately 560 million yuan, effectively reducing trade costs for enterprises engaging with South Korea [1][3][4] Group 2 - Yanji Customs has focused on key areas such as machinery imports and specialty agricultural exports, optimizing customs supervision and services to accelerate the benefits of the FTA [3] - The customs authority has provided one-on-one policy guidance, enabling companies to utilize tariff reductions effectively, exemplified by a local company saving 44,000 yuan in taxes through zero-tariff clearance for imported machinery parts [3] - The implementation of a "single window" and smart customs initiatives has improved trade facilitation, reducing the time and costs associated with customs clearance and certificate application processes [3] Group 3 - Yanji Customs is committed to deepening the implementation of FTA policies and enhancing customs facilitation measures to support Jilin enterprises in integrating more deeply into China-South Korea economic and trade cooperation [4]

Market Overview - The three major indices showed mixed performance, with the Shanghai Composite Index rising by 0.49% to 4160.01, the Shenzhen Component Index increasing by 0.09% to 14342.74, and the ChiNext Index declining by 0.37% to 3330.39 [1][2]. Sector Performance - Precious metals, industrial metals, and petrochemicals sectors performed strongly, while solar energy, pharmaceuticals, and aerospace sectors experienced fluctuations [2]. - The basic metals sector saw significant gains, with copper and aluminum industries leading the rise, as multiple stocks hit the daily limit up [6]. Stock Highlights - Notable stocks included China National Offshore Oil Corporation, China Petroleum, and China Unicom, which showed strong performance [4]. - The aluminum futures market saw a rise of over 4%, with the main contract reported at 25345 yuan/ton [8]. Biotechnology Sector - The biotechnology sector faced declines, with several companies such as Zhijiang Biology and Baipusais losing over 9% [10][11]. Solar Energy Sector - The solar energy sector faced downward adjustments, with companies like High Measurement and Maiwei experiencing drops exceeding 6% [11].

Core Viewpoint - The recent Nipah virus outbreak in West Bengal, India, has led to nearly a hundred individuals being quarantined, with the infection traced back to contaminated fresh date palm juice [2]. Group 1: Nipah Virus Overview - Nipah virus (NiV) is a highly pathogenic paramyxovirus first identified in Malaysia in 1998, characterized by a high fatality rate ranging from 40% to 75% [4][6]. - The World Health Organization (WHO) has classified Nipah virus as a priority pathogen due to its potential to cause large-scale outbreaks and the lack of effective treatments [7]. - Currently, there are no approved vaccines or specific antiviral therapies for Nipah virus, although research is ongoing, with some vaccine candidates entering clinical trials [4][34]. Group 2: Transmission and Symptoms - Nipah virus can be transmitted from animals to humans, primarily through direct contact with infected animals or their bodily fluids, and can also spread between humans, particularly in healthcare settings [12][14]. - The incubation period for Nipah virus infection typically ranges from 4 to 14 days, but can extend up to 45 days, complicating outbreak control efforts [16]. - Symptoms of Nipah virus infection can vary widely, from mild flu-like symptoms to severe neurological complications such as encephalitis, with early symptoms often being non-specific [18][19]. Group 3: Long-term Effects and Treatment - Survivors of Nipah virus infection may experience long-term neurological complications, including persistent seizures and memory issues [20]. - Treatment for Nipah virus is primarily supportive, focusing on managing symptoms and complications, as no specific antiviral drugs have been approved [22]. Group 4: Research and Development - Research into Nipah virus has identified key proteins, such as G and F proteins, as targets for vaccine development, with various candidates currently in different stages of clinical trials [34][37]. - Companies like Yiqiao Shenzhou have developed a range of research reagents related to Nipah virus, indicating a growing interest in the field of viral research and diagnostics [4][37].

● 本报记者葛瑶 国际资本对中国市场的关注度显著回升。去年境外投资者对中国市场的低配幅度从约2.5%收窄至约 1.3%，减少了约1.2个百分点的低配。瑞银全球金融市场交易部主管贺立言(Neil Hosie)日前在接受中国 证券报记者专访时表示："如果外资进一步降低低配幅度，将意味着可观的潜在资金流入。" 贺立言表示，外资情绪正从此前的观望态度转向"谨慎乐观"。在他看来，中国市场估值优势凸显、企业 治理持续改善、科技创新动能不断增强，叠加全球投资者分散化配置需求上升，配置型资金的入场窗口 有望逐渐打开。瑞银预计中国股市2026年全年涨幅约18%，盈利增速约10%，机器人、人工智能、新能 源汽车、生物科技等科技创新赛道最受关注。 外资谨慎乐观 "谨慎但乐观"，贺立言用这一表述来概括当前外资的情绪基调。他观察到，与一年前同期相比，境外投 资者的心态已发生明显转变。"今年投资者正在做大量工作来深入了解中国公司，这和去年年初相比已 经有了很大不同。"他认为，这一变化在一定程度上受2025年A股市场表现带动：上证指数全年涨幅达 18.41%，沪深300指数涨幅超17%，强劲的市场表现开始吸引全球投资者关注。 交易型资金活 ...

Group 1 - The Nipah virus outbreak in India has led to increased attention on related concept stocks, with several companies responding urgently to the situation [1] - Companies such as Capbio and Daan Gene have reported significant stock price increases, with Capbio rising by 20% and Daan Gene by 9.99% as of January 27 [2] - Various A-share listed companies are disclosing their technology and product layouts related to Nipah virus testing, including Wanfu Bio and Shengxiang Bio, which have developed specific testing kits [3][4] Group 2 - Capbio has developed a Nipah virus nucleic acid testing kit using fluorescence PCR technology, providing essential support for global quarantine and disease control monitoring [4] - Wanfu Bio has launched different product forms of the Nipah virus nucleic acid testing kit, compatible with its molecular POCT platform and other PCR systems [3] - Some companies, such as Hualan Biological and others, have clarified that they do not have any business related to Nipah virus vaccines or products [5][6]

Core Viewpoint - The outbreak of Nipah virus in West Bengal, India, highlights the urgent need for rapid and accurate diagnostic and warning capabilities in global public health systems, with the World Health Organization classifying it as a deadly zoonotic virus with a mortality rate of 40% to 75% and no specific treatment or vaccine available [1] Group 1: Company Overview - Huajian Medical Holdings Limited is a high-tech intellectual property capital operation platform focused on the life sciences sector, closely monitoring global public health dynamics and providing technical support for the prevention and control of emerging infectious diseases [1] - The company’s subsidiary, Shenzhen Carbonhua Biotechnology Co., Ltd., is a high-tech enterprise established through a strategic investment with Carbon Cloud Intelligence, focusing on molecular diagnostics and offering comprehensive solutions in research, production, and technical services [1] Group 2: Technological Solutions - Carbonhua Biotechnology has developed a dual-platform detection solution for Nipah virus, capable of supporting the entire process from rapid screening to precise tracing [1] - The intelligent fluorescent PCR rapid detection platform utilizes an AI primer design platform, integrating gene retrieval, automated primer design, and multi-dimensional performance evaluation, achieving rapid and accurate detection of high-risk pathogens like Nipah virus [2] - The high-throughput sequencing and intelligent analysis platform offers a localized sequencing solution covering both "wet experiments and dry analysis," enabling simultaneous detection and differentiation of Nipah virus and other co-existing pathogens [4] Group 3: Strategic Development - The rapid deployment of Nipah virus detection capabilities reflects the technological strength of Carbonhua Biotechnology and is a significant step in Huajian Medical's overall AI healthcare strategy [6] - The company is advancing its acquisition of Chuangye Huikang Technology Co., Ltd., aiming to establish a next-generation public health prevention paradigm that integrates AI early warning, rapid diagnosis, and ecological collaboration [6] - The product launch and strategic articulation demonstrate the company's commitment to the core paradigm of "intelligent capital driving continuous profit from knowledge," enhancing innovation efficiency and commercial value within its ecosystem through technology integration, data collaboration, and capital empowerment [6]